<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04785131</url>
  </required_header>
  <id_info>
    <org_study_id>59871A</org_study_id>
    <nct_id>NCT04785131</nct_id>
  </id_info>
  <brief_title>Prune Consumption and Bone Health in Young Women Using Hormonal Contraceptives</brief_title>
  <official_title>The Impact of Consuming California Dried Plums on Bone Health of Young Women Using Hormonal Contraceptives</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Diego State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>San Diego State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine if 12 months of consuming 50 grams of&#xD;
      dried plum daily will prevent bone loss or augment bone accrual of young adult oral&#xD;
      contraceptive (OC) users.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible participants will be assigned among three groups 1) control non-OC users, 2) control&#xD;
      OC users, and 3) dried plum OC users. OC users will be randomly allocated to the dried plum&#xD;
      OC group, which will consume 50 g dried plum daily for 12 months, or a control group, for&#xD;
      which dried plums will not be allowed and no control food will be provided.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 30, 2019</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in bone mineral density from baseline to 12 months</measure>
    <time_frame>At baseline, at 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes from baseline in bone specific alkaline phosphatase at 6 months and 12 months</measure>
    <time_frame>At baseline, at 6 months, at 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Osteoporosis Risk</condition>
  <arm_group>
    <arm_group_label>Prune group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral contraceptive users will consume 50 grams prunes daily.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral contraceptive users</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Oral contraceptive users will be monitored throughout the study period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non oral contraceptive users</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Non oral contraceptive users will be monitored throughout the study period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prune</intervention_name>
    <description>daily consumption of 50 grams prune.</description>
    <arm_group_label>Prune group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-25&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Metabolic bone disease, renal disease, cancer, CVD, diabetes mellitus, respiratory&#xD;
             disease, gastrointestinal disease, liver disease or other chronic diseases, heavy&#xD;
             smoking (more than twenty cigarettes/day) and current use of any prescription&#xD;
             medications known to alter bone and calcium metabolism&#xD;
&#xD;
          -  Regularly consumed dried plum or prune juice&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shirin Hooshmand, PhD, RD</last_name>
    <phone>6195946984</phone>
    <email>shooshmand@sdsu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shirin Hooshmand</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92182-7251</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shirin Hooshmand, PhD, RD</last_name>
      <phone>619-594-6984</phone>
      <email>shooshmand@sdsu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 3, 2021</study_first_submitted>
  <study_first_submitted_qc>March 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>March 3, 2021</last_update_submitted>
  <last_update_submitted_qc>March 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>San Diego State University</investigator_affiliation>
    <investigator_full_name>Shirin Hooshmand</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Prune</keyword>
  <keyword>Bone health</keyword>
  <keyword>Oral contraceptives</keyword>
  <keyword>Women health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

